IHE icon

iShares US Pharmaceuticals ETF

143 hedge funds and large institutions have $387M invested in iShares US Pharmaceuticals ETF in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
Holders Change %
0%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
22
Increased
48
Reduced
32
Closed
18
Calls
$411K
Puts
Net Calls
+$411K
Net Calls Change
+$44K
Name Holding Trade Value Shares
Change
Shares
Change %
FTUS
151
Flow Traders U.S.
New York
-$209K -3,085 Closed
MAWCM
152
Mine & Arao Wealth Creation & Management
California
-$116K -1,710 Closed
First Manhattan
153
First Manhattan
New York
-$48.9K -720 Closed
FFA
154
Founders Financial Alliance
North Carolina
-$40.7K -600 Closed
SSB
155
Sandy Spring Bank
Maryland
-$21.6K -318 Closed
Citigroup
156
Citigroup
New York
-$20.4K -300 Closed
PWA
157
Provenance Wealth Advisors
Florida
-$14.3K -210 Closed
Bessemer Group
158
Bessemer Group
New Jersey
-$11K -165 Closed
AAG
159
Armstrong Advisory Group
Massachusetts
-$19.3K -104 Closed
AA
160
Addison Advisors
Vermont
-$4.28K -63 Closed
S
161
SignatureFD
Georgia
-$4.07K -60 Closed
FFA
162
Frazier Financial Advisors
Ohio
-$1.02K -15 Closed